Abzu

Unlocking the future of RNA Tx with explainable AI

Abzu is a pioneering company in silico RNA therapeutics, leveraging its proprietary explainable AI to accelerate drug discovery. The company's innovative approach combines cutting-edge RNA technologies with exceptional results. Founded in 2018, Abzu has established itself as a leader in the field, providing clients with unparalleled insights and confidence to transform RNA therapeutics concepts into market-ready drugs. By utilizing its QLattice technology, Abzu generates siRNA activity models from publicly available data, creating actionable intelligence for design active siRNAs. This enables pharma companies to overcome the challenges of black-box AI and develop innovative treatments. With its measurable impact in RNA Tx design, Abzu is poised to revolutionize the pharmaceutical industry.